If you've suffered severe side effects from Ozempic, Wegovy, or other GLP-1 medications, you're not alone. Thousands are discovering these weight-loss drugs may have caused serious harm. Learn about your legal options.
Expert information to help you understand your rights and options
Popular weight loss and diabetes drugs Ozempic and Wegovy face mounting lawsuits alleging serious gastrointestinal injuries. This guide explains the litigation status, what injuries qualify for claims, and how to evaluate whether you have a case against manufacturers.
As GLP-1 litigation consolidates into multidistrict litigation, settlement values remain uncertain but comparable cases provide guidance. Understand what factors determine compensation, how injury severity affects claims, and what similar pharmaceutical settlements suggest.
Qualifying for GLP-1 drug litigation requires documented use of specific medications and diagnosed gastrointestinal injuries. Learn the eligibility criteria attorneys evaluate, what medical records strengthen claims, and how to determine if your injuries meet filing thresholds.
GLP-1 medications like Ozempic and Wegovy have been linked to gastroparesis—a serious condition where the stomach cannot empty properly. Learn about the scientific evidence, warning signs to watch for, and why this side effect drives current litigation.
Severe bowel obstructions requiring hospitalization and surgery have been reported in Ozempic users. Learn how these life-threatening blockages occur, the emergency symptoms to recognize, and how victims are pursuing manufacturers for inadequate warnings.